This commonsense, bipartisan bill would ensure that pharmacies accused of fraud stop receiving payments under Medicare Advantage and Medicare Prescription Drug Plans while they’re investigated.
While pharmacies facing substantive allegations of fraud need to be investigated, suspending payments to them under Medicare prescription drug plans goes too far and won't serve as a deterrent.